Background--Nuclear receptor Rev-erba plays important roles in circadian clock timing, lipid metabolism, adipogenesis, and vascular inflammation. However, the role of Rev-erba in atherosclerotic lesion development has not been assessed in vivo.
A therosclerosis is a complex and chronic inflammatory disease of the vessel walls. A crucial step preceding the formation of atherosclerotic lesions is monocyte migration into the arterial wall and their differentiation into macrophages. 1 Macrophages are important organizers of plaque inflammatory responses. 2 Monocytes are heterogeneous cells, which, depending on the microenvironment, differentiate into distinct macrophage subsets (M1 and M2). 3 Recent studies have revealed that the heterogeneity of macrophages may confer both atherogenic and atheroprotective properties. [4] [5] [6] M1 macrophages activated by interferon (IFNc) or lipopolysaccharide (LPS) are powerful effectors that can kill microorganisms and secrete proinflammatory cytokines such as tumor necrosis factor a (TNFa), interleukin-6 (IL-6), and interleukin-12 (IL-12), 7, 8 which have generally considered atherogenic functions. M2 macrophages polarized by interleukin-4 (IL-4) or interleukin-13 (IL-13) reduce the inflammatory response and produce antiinflammatory factors such as interleukin-10 (IL-10) and transforming growth factor b. M2 macrophages are thus able to remove metabolic debris, enhance angiogenesis, facilitate tissue remodeling and repair, 9 and likely act in an atheroprotective fashion. This balance in macrophage M1/M2 activity is suggested to play an important role in the pathogenesis of atherosclerosis. 10, 11 Rev-erba (Nr1D1) is a member of the nuclear receptor (NR) superfamily. 12 The NR1D1 gene is located on chromosome 17, and is transcribed from the antisense strand of the thyroid receptor a gene (TRa). Due to the lack of a ligand, Rev-erba was considered as an "orphan receptor" until 2007, when Raghuram et al found protoporphyrin or heme as ligands of Rev-erba and Rev-erbb. 13, 14 Rev-erba is expressed in a variety of tissues and cell types such as the heart, liver, adipose tissue, skeletal muscle, vascular smooth muscle cells (VSMCs), and macrophages. 12, 15, 16 Recent studies have confirmed that Rev-erba is not only an important component of the biological clock, but also a regulator of energy balance, inflammation, and immunity, and may thus play an important role in metabolic and cardiovascular diseases. 17, 18 Emerging evidence suggests that Rev-erba affects the pathogenesis of atherosclerosis. Rev-erba has been implicated in the development of atherosclerosis by decreasing plasma triglyceride-rich lipoproteins. 19 In human macrophages, Rev-erba inhibits the induction of Toll-like receptor 4, thereby reducing cytokine production induced by LPS, which prompts Rev-erba antiinflammatory functions and a potential atheroprotective action. 20 Furthermore, Rev-erba may exert atheroprotective functions through negative regulation of plasminogen activator inhibitor (PAI)-1, an important inhibitor of the fibrinolytic cascade that promotes the development of atherothrombosis. Taken together, Rev-erba regulates plasma glucose and lipid metabolism as well as inflammationm and may thus affect the development of atherosclerosis. However, its role in atherosclerosis has not been assessed in vivo.
In the present study, we investigate the consequences of macrophage Rev-erba knock-down in the development of atherosclerotic lesions in LDLr À/À mice using the bone marrow transplantation technique and elucidate the possible underlying molecular mechanisms.
Methods Animals
All animal experiments were approved by the Ethics Committee for Animal Experiments of Jinan University and performed in compliance with Chinese government guidelines. C57BL/6 mice were obtained from Animal Center of Guangdong Province. Homozygous LDL receptor knockout (LDLr
; C57BL/6) mice were obtained from the Jackson Laboratory (Bar Harbor, ME) as mating pairs and bred at the Animal Centre of Jinan University. Mice were housed in sterilized filter-top cages and given unlimited access to food and water with 12/12 dark/light cycles. Mice were maintained on sterilized regular chow, containing 4.3% (w/w) fat and no cholesterol (No. 201, Baiyun animal diet factory, Guangzhou, China), or fed a semisynthetic Western-type diet, containing 15% (w/w) fat and 0.25% (w/w) cholesterol (No. 202, Baiyuan animal diet factory). Drinking water was supplied with antibiotics (83 mg/L ciprofloxacin and 67 mg/L polymyxin B sulphate) and 6.5 g/L sucrose.
Irradiation and Bone Marrow Transplantation
To induce bone marrow aplasia, female C57BL/6 mice (8 weeks of age) were exposed to a single dose of 9 Gy (0.19 Gy/minute, 200 kV, 4 mA) total body irradiation, using a c-ray source (Jixing Group) with a 6-mm aluminium filter. The mice were then fed chow diet for 8 weeks. Bone marrow cell suspensions were isolated from C57BL/6 mice by flushing the femurs and tibias with PBS. Single-cell suspensions were prepared by passing the cell mass through a cell strainer with 27 pond needle, and bone marrow cells (1.0910 7 ) were transduced with either H1.shNT or H1.shRev-erba lentivirus in the presence of 10 lg/mL DEAE-dextran (multiplicity of infection [moi]=15). Eighteen hours posttransduction, the cells sorted by flow cytometry; GFP-positive cells were collected and injected into the tail vein of the irradiated recipients (1x10 7 cells/mouse, n=10 mice per group).
Atherosclerotic Lesion Analysis
Atherosclerotic plaque burden in the aorta (aortic root to the iliac bifurcation) was determined by oil red O staining.
Transplanted LDLr À/À mice were anesthetized by intraperitoneal injection of 3 mg of xylozine and 3 mg of ketamine after 11 weeks on the Western-type diet, and blood samples were collected via heart puncture for lipid profile analyses. The left ventricle of the heart was perfused first with PBS and then with a fixative solution (4% paraformaldehyde, 5% sucrose, 50 mmol/L EDTA, pH 7.4). After removal of outside connecting tissue and fat, the aorta was dissected from the aortic root to the iliac artery under the dissection microscope, cut open longitudinally in situ, and immersed in the fixative for 12 hours before being rinsed with 19 PBS and stained with oil red O (Sigma). Stained aortas were washed in 60% isopropanol and imaged with a Nikon CoolPix digital camera. Quantification of the percentage of aortic surface area occupied by oil red O positive plaque was performed using digital image analysis (Simple PCI, C-Imaging). The heart and proximal portion of aortic root were also fixed and embedded in OCT. Subsequently, the aortic root area was sliced. The atherosclerotic lesion areas in oil red O-stained cryostat sections of the aortic root were quantified using the Leica image analysis system, consisting of a Leica DMRE microscope coupled to a video camera and Leica Qwin Imaging software (Leica Ltd. 
Isolation and Culture of Bone Marrow-Derived Macrophages
Mononuclear phagocyte progenitor cells derived from femoral and tibial bone marrow were propagated in the presence of M-CSF. This macrophage growth factor secreted by L929 cells was used in the form of L929 cell-conditioned medium. The progenitor cells proliferate and differentiate through monoblast, promonocyte, and monocyte stages before maturing to macrophages. For the observation of Rev-erba knock-down effect on monocyte differentiation, bone marrow cell suspensions were isolated from C57Bl/6 mice by flushing the femurs and tibias with PBS. Single-cell suspensions were prepared by passing the cell mass through a cell strainer with 27 pond needle, and bone marrow cells (1.0910 7 ) were transduced with either H1.shNT or H1.shRev-erba lentivirus in the presence of 10 lg/mL DEAE-dextran (multiplicity of infection [moi]=15). Eighteen hours posttransduction, the cells were sorted by flow cytometry, and GFP-marker-positive cells with green were collected and cultured at a density of 2910 6 cells/well in six-well plastic culture dishes for 6 days with the macrophage growth factor from L929 cells. Alternatively differentiated macrophages (M2) were obtained by stimulating monocytes during differentiation with human IL-4 (15 ng/mL). M1 macrophage differentiation was induced by incubating the monocytes with LPS (100 ng/mL). The effect of Rev-erba overexpression on monocyte differentiation was observed by carrying out the same protocol as above. Heme was added at 20 lmol/L in the differentiation medium.
Western Blotting
Protein specimens for sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) were prepared by homogenizing C57BL/6 bone marrow cells, peripheral blood monocytes, and peritoneal macrophages, macrophages isolated from lentivirus-shNT, or lentivirus-shRev-erba BM transplantation recipient mice after 11 weeks on the Western-type diet in 250 mmol/L Tris-HCl, pH 6.8, 8% SDS, protease inhibitor cocktail (Roche Diagnostics). The crude extracts were cleared by centrifugation at 16 000g for 3 minutes, and protein concentration of the supernatant was determined by the DC assay (BioRad). Equal amounts of the proteins were electrophoresed and Western blotted using the mouse monoclonal primary antibody against Rev-erba (AT3093a, Abgent Biotech). The bound antibodies were visualized by using horseradish peroxidase-conjugated goat antimouse IgG (Bio-rad) and enhanced chemiluminescence (ECL; GE Healthcare).
Analysis of Plasma Lipids
Total plasma cholesterol (Kit 1489232, Roche Diagnostics GmbH), choline-containing phospholipids (Kit 990-54009, Wako Chemicals GmbH) and triglycerides (Kit 1488872, Roche Diagnostics) were measured using enzymatic methods.
Quantification of Macrophage mRNAs
Total RNA was isolated from myeloid cell-derived macrophages and peritoneal macrophages from experimental animals with the RNeasy Mini kit (Qiagen) according to the manufacturer's instructions. The RNA (2 lg) was treated with DNase I (Promega) in the presence of RNase Inhibitor (Promega) and reverse-transcribed by using Superscript II (Invitrogen) and random hexamer primers (Applied Biosystems). Each RNA sample was amplified in triplicate for the genes of interest and two housekeeping markers, 36B4 and 18S rRNA, on a 7000 Sequence Detection System (Applied Biosystems) by using SYBR-green (ABgene). Sequences of the primers used are listed in Table S1 . The threshold was set in the linear range of fluorescence, and a threshold cycle (Ct) was measured for each well. Data were analyzed as described previously. 21 
Immunohistochemical Analysis
Human atherosclerotic plaques were removed from patients eligible for surgical carotid endarterectomy. The carotid arteries were fixed with paraformaldehyde and embedded in paraffin. Paraffin-embedded arteries were cross-sectioned into 4-lm thick pieces, dewaxed, rehydrated, and pretreated by boiling in 0.01 mol/L citrate buffer (pH 6.0) for 10 minutes in a microwave oven (750 W). Sections were incubated with the mouse monoclonal antihuman Rev-erba antibodies (1:150) overnight. Subsequently, the sections were incubated with biotinylated secondary antibodies for 30 minutes, followed by 30 minutes incubation with ABComplex/HRP. Finally, the sections were stained with 3, 30-diaminobenzidine (DAB) and counterstained with hematoxylin. The slides were mounted under glass coverslips and analyzed by light microscope. For immunofluorescence double staining, the sections were blocked with 1% BSA in PBS after microwave 
Statistical Analysis
The Kolmogorov-Smirnov test was used to determine whether each variable had a normal distribution. When data were normally distributed and variances were similar across comparison groups, the statistical significance of data between the groups was assessed by analysis of variance (ANOVA). Except for the date on determination of lesion area between the groups, statistical significance was estimated by Wilcoxon rank-sum test. All values are reported as mean AESEM. Analyses were performed using the SPSS (version 16.0; APSS), statistical package and the P<0.05 values were regarded as statistically significant.
Results

Increased Atherosclerotic Lesions in LDL Receptor Deficient Mice With Haematopoietic Nuclear Receptor Rev-erba Knock-Down
The expression of Rev-erba protein in mouse bone marrow, peripheral blood monocytes, and peripheral macrophages stimulated with LPS or IL-4 was monitored by Western blotting analysis and showed the presence of Rev-erba in all of these cell populations ( Figure 1A , left panel). Moreover, we assessed the expression of Rev-erba in LDLr À/À mice fed normal chow or a high fat diet, and found no diet-dependency of Rev-erba protein expression in bone marrow cells or peritoneal macrophages ( Figure 1A , right panel). To study the effects of Rev-erba on the development of atherosclerosis, wild-type C57BL/6 mouse bone marrow was transduced with lentivirus-shRev-erba or a nontargeting shRNA lentivirus (lentivirus-shNT), followed by transplantation into LDLr À/À mice. To induce atherosclerotic lesion development, the transplanted mice were allowed to recover for 8 weeks and then fed a Western-type diet for 11 weeks, followed by analysis of atherosclerotic lesion size in the aortic root and in the aorta en face. Efficacy of the Rev-erba knock-down was assessed in peripheral macrophages of the animals after Figure 1C ). Knock-down of Rev-erba also led to a significant increase in atherosclerotic plaque burden compared with the control mice by en face analysis, with an approximately 70% increase in lesion area ( Figure 1D ). Histological analysis of aortic root lesions revealed no significant differences in macrophages ( Figure 1C , middle panel) or necrotic area ( Figure 1C , bottom panel) in plaques of shNT and shRev-erba bone marrow recipient mice. In summary, bone marrow Rev-erba knock-down resulted in increased atherosclerotic lesion size, identifying Rev-erba in haematopoietic cell lineages as an antiatherogenic factor.
Plasma Lipids Are Not Modulated by Haematopoietic Rev-erba Knock-Down
Next, we assessed the potential influence of Rev-erba knock-down on plasma lipids. Our data showed no significant difference in plasma total cholesterol, triglyceride, or choline-containing phospholipid concentrations between the mice injected with lentivirus-shRev-erba-transduced bone marrow and the control mice (Table) .
Rev-erba Promotes the Appearance of an Anti-Inflammatory M2 Macrophage Like Phenotype
The mechanism underlying the elevated atherosclerotic lesion area upon haematopoietic Rev-erba knock-down was assessed. An emerging concept is that a shift of macrophage polarity plays an important role in atherosclerosis, 10 M1 being effective in secreting proinflammatory cytokines whereas M2 dampen the inflammatory response by producing antiinflammatory factors. M1 and M2 are the two extremes, macrophage polarization being continuous as can be monitored using a series of markers. transplantation recipient mice. The data (Figure 2 ) revealed that when bone marrow cells were differentiated into macrophages by stimulation with IL-4, Rev-erba knock-down resulted in reduced expression levels of all M2 markers (arg1, MR, YM1/2) as compared to differentiated macrophages from the control animals. By contrast, LPS stimulation of Rev-erba knock-down macrophages resulted in an increased expression of the M1 marker iNOS (Figure 2) . To assess the impact of Rev-erba overexpression on macrophage markers, we next prepared a lentivirus expressing the Rev-erba cDNA (Lentivirus-Rev-erba) and overexpressed the nuclear receptor in mononuclear cells from bone marrow of wild type C57BL/6 mice. Rev-erba overexpression resulted, upon IL-4 stimulation, in increased expression levels of all M2 markers (arg1, MR, YM1/2). By contrast, LPS stimulation of these cells resulted in a decreased expression of the M1 marker iNOS (Figure 3 ). mRNA levels of other M1 macrophage markers, such as TNFa, IL-1, IL-6, IL-12, MCP-1, and CCL5, tended to increase after LPS stimulation of the Rev-erba knock-down macrophages, whereas they displayed a tendency toward reduction in Rev-erba overexpressing cells ( Figure S1 ). The results indicated that Rev-erba overexpression skews monocyte differentiation toward the M2 macrophage subtype (Figure 3 ).
Rev-erba Knock-Down Impairs Alternative Macrophage Activation in Vivo
To explore the effect of Rev-erba on M1-type or alternative macrophage activation in vivo, we injected LPS or IL4, respectively, in shNT?LDLr À/À (Lenti-shNT) or shRev-erba? LDLr À/À mice (Lenti-shRev-erba) mice which were fed Western-type diet. We found that peritoneal CD80 + macrophages were increased significantly with LPS stimulation in shRev-erba?LDLr À/À mice, and a clear elevation of iNOS (M1 marker) mRNA was detected in the peritoneal macrophages. The peritoneal CD206 + macrophages monitored after IL4 injection showed a dramatic decrease in shRev-erba? LDLr À/À mice, and the M2 marker mRNAs including arg1, Ym1/2, and MR (CD206) were significantly reduced. The data indicated that Rev-erba enhances M2 macrophages differentiation in vivo (Figure 4 ).
Heme Primes Monocyte Differentiation Into M2 Macrophages in Vitro
To study the potential effect of the Rev-erba ligand heme on macrophage polarization markers, bone marrow cells from wild type C57BL/6 mice were differentiated into macrophages in the presence of heme (20 lmol/L). The data ( Figure 5 , left panels) indicated that heme increased all M2 markers (arg1, MR, YM1/2) while Rev-erba knock-down abolished the effect of heme ( Figure 5 , right panels). These results suggested that , n=10). heme stimulation promotes a similar macrophage phenotype as Rev-erba overexpression, lending further support to the suggested role of Rev-erba in macrophage function.
Relative iNOS mRNA quantity
Rev-erba is Present in the Macrophages of Human Atherosclerotic Plaques
To assess the presence of Rev-erba in human carotid atherosclerotic plaques, immunohistochemical analysis of (Lenti-shRev-erba) mice were fed an atherogenic diet for 6 weeks and challenged with IL-4 at 500 ng/30 g body weight for 2 days. Peritoneal cells were stained with antibodies against CD206 (M2) and identified by flow cytometry. The values represent the percentages of individual macrophage subtypes. Peritoneal macrophages were isolated from the mice and the expression levels of M2 macrophages markers were measured by qPCR. The bars represent the meanAESEMfrom at least three separate experiments each analyzed in triplicate; statistical analysis was performed by Kolmogorov-Smirnov test followed by two-factor ANOVA, **P<0.01 and ***P<0.001. arg1 indicates arginase 1; Ym1/2, chitinase-like proteins, MR, mannose receptor. LDLr Rev-erba in plaque sections was performed. Significant Rev-erba immunoreactivity was observed in the intimal region of the atherosclerotic vessel wall ( Figure 6A ). Immunofluorescence microscopy analysis showed the colocalization of Rev-erba staining with that of CD68, identifying the Rev-erba positive cells as macrophages ( Figure 6B ). This result was confirmed by staining sections of carotid lesions from several additional patients ( Figure S2 ).
Discussion
The present study demonstrates that haematopoietic Rev-erba knock-down increases the size of atherosclerotic lesions in LDLr À/À mouse, thus providing evidence for an antiatherogenic role of macrophage Rev-erba. The possible molecular mechanisms through which Rev-erba could influence lesion development were evaluated. Our results in vitro and in vivo strongly suggest that Rev-erba promotes the differentiation of macrophages towards the M2 phenotype. Atherosclerosis is a chronic inflammatory disease manifested as vessel wall lesions 1 in which macrophages play key roles in the inflammatory response and lipids accumulation. Heterogeneity of circulating monocytes and the functional diversity of macrophages likely influence plaque formation and phenotype. 22, 23 Our in vitro data and experiments in live mice provide the first evidence that Rev-erba regulates the differentiation of macrophages, resulting in a more antiinflammatory M2 macrophage state. We therefore find it likely that Rev-erba may also affect the development of atherosclerosis by enhancing the antiinflammatory function of macrophages in the large vessel wall. Furthermore, Rev-erba acts as an integrator of circadian rhythms and metabolism including that of lipids. 18, 24 It downregulates expression of the apolipoprotein CIII component of triglyceride-rich lipoproteins which are associated with increased risk of cardiovascular disease 19, 25, 26 in human hepatoblastoma cells. Interestingly, in our study, no significant difference was observed in plasma total cholesterol, triglyceride, or choline-containing phospholipid concentrations between the recipients of the Rev-erba knock-down and control bone marrow. The liver is the major organ controlling lipoprotein metabolism, so it is thus not surprising that Rev-erba knock-down in macrophages had no significant influence on plasma lipids. Based on the present results, we therefore hypothesize that the observed impact of Rev-erba on M2 monocyte polarization may be an important factor contributing to the increase of atherosclerotic lesion size in recipients of Rev-erba deficient bone marrow. A large body of data confirms the close relation between cardiovascular disease and biological rhythms. A shift of sleep-wake rhythms is an independent risk factor of cardiovascular disease. [27] [28] [29] In addition, according to clinical observations, atherosclerosis-based cardiovascular disease deaths occur mostly in the morning, 30, 31 indicating a link between CVD and the biological clock. Our results suggested that changes of hematopoietic Rev-erba expression are associated with macrophage polarization and cytokine expression in vivo. Rev-erba repress IL10 expression by direct binding to the IL10 promoter, 32 and the recent data of Gibbs et al. 33 which demonstrate that Rev-erba mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines, together identify a potential mechanistic connection between biological rhythms and atherosclerosis, its complications and clinical manifestations. Our study reveals for the first time that a clock gene affects the balance of M1/M2 markers, and may thus provide new clues for elucidation of the mechanisms underlying the connections of CVD with biological rhythms. The detailed mechanism through which Rev-erba affects monocyte differentiation into M2 macrophages is thus far unknown. Peroxisome proliferator-activated receptor c (PPARc) is another nuclear receptor with antiinflammatory properties, 34, 35 and it is reported to enhance the differentiation of monocytes into an M2 state. 36 Interestingly, PPARa and c are capable of binding a RevDR-2 sequence located in the Rev-erba gene promoter, hence activating its transcription. 37 Whether the PPARs and Rev-erba operate in concert to regulate monocyte differentiation is therefore an important topic for future investigation. Given the multiple roles of Rev-erba in lipid metabolism, adipogenesis, and vascular wall pathophysiology, Rev-erba represents a promising target for the treatment of metabolic diseases and atherosclerosis. 38 Identification of synthetic ligands which can be pharmacologically used, provides a means of controlling Rev-erba function. 17 Recently, heme and synthetic small molecular ligands for Rev-erba were shown to be effective modulators of adipogenesis. 39 Our observation that heme mimics the impact of Rev-erba overexpression in promoting M2 monocyte polarization suggests that Rev-erba agonists may also be potential tools to combat atherosclerosis.
In conclusion, our data show that haematopoietic Rev-erba knock-down increases the development of atherosclerotic lesions LDLr À/À mice, demonstrating an anti-atherogenic role of Rev-erba. Moreover, we suggest that promotion of monocyte polarization into a M2 macrophage phenotype contributes to the effect of Rev-erba. 
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